4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-026135
Chairman and CEO gave up 37,205 shares (to pay taxes)
- Chairman and CEO acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2022-03-16 | Grant or award | +20,000 | $2.59 | $51,800 | 5,790,563 | D |
| KAZIMI A J Chairman and CEO | 2022-03-20 | Shares withheld for taxes | −37,205 | $2.74 | $101,942 | 5,753,358 | D |
| Derivatives | |||||||
| KAZIMI A J Chairman and CEO | 2022-03-16 | Grant or award · Options (right to buy) | +80,000 | 80,000 | D | ||
Loading xslF345X03/doc4.xml…